MHRA Extends Licence for Blincyto: What It Means for ALL Patients🪪
The Medicines and Healthcare products Regulatory Agency (MHRA) has granted a licence extension for Amgen’s Blincyto (blinatumomab), expanding…
FDA approved
Breakthrough in Lung Cancer: Imfinzi’s FDA Approval for Limited-Stage SCLC Patients
AstraZeneca’s (AZ) Imfinzi (durvalumab) has received approval from the US Food and Drug Administration (FDA) for treating adults…
INNOVATION VERTE : INSIDE LOOK AT PUNE’S LUPIN RESEARCH PARK R&D FACILITIES
Lupin Limited, a prominent global pharmaceutical company, has announced that its Research and Development facility at the Lupin…
Gland Pharma’s Latanoprost Solution: FDA Approved
Gland Pharma has received approval from the United States Food and Drug Administration (USFDA) for its Latanoprost Ophthalmic…